- Home
- INO
as 11-15-2024 3:36pm EST
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
| Founded: | 1979 | Country: | United States |
| Employees: | 122 | City: | SAN DIEGO |
| Market Cap: | 110.7M | IPO Year: | 1998 |
| Target Price: | $21.00 | AVG Volume (30 days): | 320.4K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.45 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.20 - $14.75 | Next Earning Date: | 11-14-2024 |
| Revenue: | $203,413 | Revenue Growth: | -76.18% |
| Revenue Growth (this year): | -60.41% | Revenue Growth (next year): | -38.68% |
Latest Inovio Pharmaceuticals Inc. News
INO Breaking Stock News: Dive into INO Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023)
MT Newswires
2 days ago
RBC Lowers Price Target on Inovio Pharmaceuticals to $6 From $7, Keeps Sector Perform, Speculative Risk
GuruFocus.com
3 days ago
Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ...
Pharma Voice
3 days ago
Where are they now? 4 biotechs that soared then crashed during the pandemic
Motley Fool
3 days ago
Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript
Associated Press Finance
3 days ago
Inovio: Q3 Earnings Snapshot
PR Newswire
3 days ago
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
PR Newswire
4 days ago
Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial
Compare INO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INO Inovio Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.